INHA and ovarian granulosa tumour: For example, inhibin alpha positivity has been described in 41–100% of granulosa cell tumors of the ovary [10,11,12], 25–100% of adrenocortical carcinomas [13,14,15,16], 0–100% of mucinous carcinomas of the ovary [17,18,19,20], 0–63% of serous high-grade carcinomas of the ovary [12,21,22], 0–60% of Brenner tumors of the ovary [12,22,23], 0–75% of endometroid carcinomas of the ovary [12,18], and 0–16% of pheochromocytomas [14,15,16,24,25,26,27,28,29].